Global Pharmaceutical Gelatin Market
Global Pharmaceutical Gelatin Market Size Set to Touch USD 1.8 Billion by 2029
Published | 07 July 2023
Global pharmaceutical gelatin market is flourishing because of the growing focus on the management of increasing prevalence of chronic illnesses, favorable properties of gelatin, and the launch of advanced pharma gelatin.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global pharmaceutical gelatin market size at USD 1.22 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global pharmaceutical gelatin market size to grow at a CAGR of 5.48% reaching a value of USD 1.76 billion by 2029. Major growth drivers for the global pharmaceutical gelatin market include an increasing need for pharmaceutical-grade gelatin, the growing prevalence of chronic illnesses, rapidly aging world population, and the progressing developments in the utilization of gelatin nanoparticles in medications and vaccines. The expanding utilization of gelatin in cosmetic applications, its inherent functionalities, as well as its biomedical applications in wound dressing and healing, gene therapy, tissue engineering, implants, and bone substitutes, are further fueling the expansion of the market. Also, the increasing progress in utilizing gelatin for drug delivery purposes is expected to propel the market expansion of pharmaceutical gelatin during the forecast period. However, shift towards non-gelatin capsules is anticipated to hinder the overall market growth.
Global Pharmaceutical Gelatin Market – Overview
Pharmaceutical gelatin, derived from collagen extracted from animal body parts, is a transparent, long-lasting, inherently tasteless, and odorless food product. It possesses a dry and brittle texture when dry, while being flexible and rubbery when moist. It finds extensive applications as a gelling agent in the pharmaceutical industry for drugs, vitamins, medicines, photographic films & documents, as well as cosmetics. The production process for hard gelatin capsules involves immersing them in a warm bath of gelatin solution, followed by drying, pinning, and cutting of cap and body components, which are then assembled for distribution. These capsules are typically filled with dry forms of pharmaceutical or supplemental products by pharmaceutical or health companies. On the other hand, the manufacturing of soft gelatin capsules begins with the creation of two sheets of soft gelatin, each passing through a die to achieve the desired capsule size and shape. During capsule production, the medication or health supplements are filled with a liquid dose simultaneously. The dose and layer can serve as binding agents to eliminate unpleasant taste and odor, while also facilitating product identification. The specific gelatin melt characteristic also plays a significant role in the controlled and rapid release of medicines. Gelatin is also utilized in the production of suppositories.
Impact of COVID-19 on Global Pharmaceutical Gelatin Market
COVID-19 pandemic adversely affected the global pharmaceutical gelatin market. Initially, the market experienced disruptions in supply chains and production capacity limitations due to lockdowns, travel restrictions, and disruptions in transportation and logistics. These challenges led to difficulties in procuring raw materials for gelatin production and resulted in limited availability of pharmaceutical gelatin. Also, the pharmaceutical industry as a whole faced delays in clinical trials, regulatory approvals, and new product launches, which indirectly affected the demand for gelatin. However, as the pandemic situation improved and healthcare systems stabilized, the global pharmaceutical gelatin market started showing positive signs of recovery. There was a renewed focus on R&D, including the development of vaccines and therapeutics, which increased the demand for gelatin. Pharmaceutical companies began diversifying their supplier base and exploring alternative sourcing options to enhance supply chain resilience. The market witnessed a gradual rebound in demand for gelatin as healthcare needs resumed, and the industry adapted to the new normal.
Global Pharmaceutical Gelatin Market – By Function
Based on function, the global pharmaceutical gelatin market is divided into Stabilizing Agent, Thickening Agent, and Gelling Agent segments. The stabilizing agent segment holds the highest share in the global pharmaceutical gelatin market. Stabilizing agents are essential components in the production of gelatin-based pharmaceutical formulations, as they help maintain the stability, integrity, and shelf life of the products. These agents prevent gelatin from undergoing degradation, aggregation, or changes in physical and chemical properties. They play a crucial role in ensuring the quality and efficacy of pharmaceutical gelatin in various applications, including capsules, coatings, and drug delivery systems. The high demand for stabilizing agents is driven by the need for reliable and consistent gelatin formulations that meet regulatory requirements and deliver optimal performance in pharmaceutical applications.
Major players operating in the global pharmaceutical gelatin market include Gelita AG, Trobas Pharmaceutical gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, Gelco International, Norland Products Inc, Lapi Gelatine S.p.a, and Trobus Gelatine B.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- Pharmaceutical Gelatin Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Source (Porcine, Bovine Skin, Bovine Bone, Marine, Poultry); By Function (Stabilizing Agent, Thickening Agent, Gelling Agent); By Type (Type A, Type B); By Application (Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Publish Date: July 2023
Favorable properties of gelatin and launch of advanced pharma gelatin are projected to propel the expansion of the global pharmaceutical gelatin market during the forecast period between 2023 and 2029.
Relevant Press Releases
- Global Cold Plasma Market flourishing at a CAGR of 18.3%: Expected to touch USD 5.8 billion by the year 2027
- Global Pacemakers Market Thriving: Projected to touch USD 5.4 Billion by 2027, growing at the CAGR of 3 % during the forecast period (2021-2027)
- Lateral Epicondylitis (Tennis Elbow) Market Gaining Momentum—Projected to Reach USD 10,734.53 Million by 2027
- Global Recombinant Cell Culture Supplements Market to Witness a CAGR of 12.5% during Forecast Period
- Japan Medical Gloves Market Registering Impressive Growth: Forecast to Grow at a CAGR of 16.4% by 2028